天眼查App显示，近日，深圳市万辰眼镜有限公司成立，法定代表人为厉万振，注册资本10万人民币， 经营范围为一般经营项目是：眼镜销售（不含隐形眼镜）；箱包销售；日用品销售；服装服饰零售；技 术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；国内贸易代理。（除依法须经批准的 项目外，凭营业执照依法自主开展经营活动），许可经营项目是：无。 ...

Core Insights - Ningxia Boming Qianjing Glasses Co., Ltd. has been established with a registered capital of 494,596 RMB [1] - The company is engaged in the sale of glasses (excluding contact lenses) and various optical materials [1] - The business scope includes the operation of Class III medical devices, rehabilitation aids, and wellness services [1] Company Overview - The legal representative of the company is Zhang Ziyi [1] - The registered capital is approximately 0.4946 million RMB [1] - The company will operate under the approval of relevant authorities for specific projects [1] Business Activities - The company will sell glasses and optical materials, and provide rehabilitation aid services [1] - It will also offer wellness services that are non-medical in nature [1] - Rental services (excluding licensed rental services) are part of the business activities [1]

天眼查App显示，近日，内江明瞳眼镜有限公司成立，法定代表人为李萍，注册资本1万人民币，经营 范围为一般项目：眼镜销售（不含隐形眼镜）；光学玻璃销售；健康咨询服务（不含诊疗服务）；康复 辅具适配服务；租赁服务（不含许可类租赁服务）；第二类医疗器械销售；第二类医疗设备租赁；第一 类医疗器械销售；养生保健服务（非医疗）；保健食品（预包装）销售；食品销售（仅销售预包装食 品）；日用百货销售；日用品销售；办公用品销售；五金产品零售；家用电器销售。（除依法须经批准 的项目外，凭营业执照依法自主开展经营活动）许可项目：第三类医疗器械经营。（依法须经批准的项 目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）（涉及 国家规定实施准入特别管理措施的除外）。 ...

民生加银持续成长混合A（007731）成立日期2019年9月24日，最新规模13.94亿。今年以来收益 25.57%，同类排名3083/8136；近一年收益23.58%，同类排名3022/8056；成立以来收益79.86%。 民生加银持续成长混合A（007731）基金经理为朱辰喆、范明月。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 从博士眼镜十大流通股东角度 数据显示，民生加银基金旗下1只基金位居博士眼镜十大流通股东。民生加银持续成长混合A （007731）三季度增持41.87万股，持有股数191.87万股，占流通股的比例为1.23%。根据测算，今日浮 亏损失约289.72万元。 11月21日，博士眼镜跌5.06%，截至发稿，报28.31元/股，成交1.45亿元，换手率3.22%，总市值64.51亿 元。 截至发稿，朱辰喆累计任职时间3年343天，现任基金资产总规模17.92亿元，任职期间最佳基金回报 10.8%， 任职期间最差基金回报-7.15%。 资料显示，博士 ...

Group 1 - Shanghai Baojing Island Glasses Co., Ltd. has been established with a registered capital of 100,000 RMB [1] - The legal representative of the company is Huang Hai [1] - The business scope includes general projects such as glasses sales (excluding contact lenses), lens processing, optical instrument sales, optical glass sales, and rehabilitation aid adaptation services [1] Group 2 - The company is authorized to operate third-class medical devices, subject to approval from relevant authorities [1] - The company can conduct business activities independently based on its business license, except for projects that require legal approval [1]

Core Insights - Shanghai Puliao Optical Co., Ltd. has been established with a registered capital of 500,000 RMB [1] - The company is engaged in the sale of glasses (excluding contact lenses) and the sale of Class II medical devices [1] - The company is also involved in the leasing of Class III medical equipment, which requires approval from relevant authorities [1] Business Scope - General projects include the sale of glasses, cosmetics retail, personal hygiene products sales, daily miscellaneous goods sales, Class I medical devices sales, and electronic products sales [1] - The company operates under a business license and can independently conduct business activities not requiring prior approval [1] - Specific business activities are subject to approval and must comply with relevant departmental regulations [1]

Core Viewpoint - Dr. Optical's stock price increased by 5.11% to 31.66 CNY per share, with a trading volume of 279 million CNY and a turnover rate of 5.93%, resulting in a total market capitalization of 7.214 billion CNY [1] Group 1: Company Overview - Dr. Optical Chain Co., Ltd. is located in Shenzhen, Guangdong Province, and was established on April 23, 1997, with its listing date on March 15, 2017 [1] - The company's main business involves optical retail, with revenue composition as follows: optical glasses and fitting services 68.65%, finished glasses series products 19.47%, contact lens series products 10.80%, and others 1.09% [1] Group 2: Shareholder Information - Minsheng Jia Yin Fund's Minsheng Jia Yin Sustained Growth Mixed A (007731) is among the top ten circulating shareholders of Dr. Optical, having increased its holdings by 418,700 shares to a total of 1.9187 million shares, representing 1.23% of circulating shares [2] - The fund has achieved a year-to-date return of 28.25%, ranking 2995 out of 8140 in its category, and a one-year return of 25.27%, ranking 3257 out of 8057 [2] Group 3: Fund Manager Performance - The fund manager Zhu Chenzhe has been in position for 3 years and 340 days, managing assets totaling 1.792 billion CNY, with the best fund return during his tenure at 10.69% and the worst at -7.37% [3] - Co-manager Fan Mingyue has been in position for 303 days, managing assets of 1.857 billion CNY, with the best fund return at 26.02% and the worst at -3.15% [3]

Core Viewpoint - Chengdu Tianqi Xiaoyanjing Co., Ltd. has been established with a registered capital of 500,000 RMB, indicating a new player in the optical and healthcare market [1] Company Overview - The legal representative of the company is Yang Xuecong [1] - The company is involved in a wide range of business activities, including the sale of glasses (excluding contact lenses), internet sales, and various medical and health-related products [1] Business Scope - The company’s business scope includes: - General projects: sales of glasses, internet sales (excluding licensed goods), sales of second-class medical devices, sales of pre-packaged health foods, sales of optical glass, and health services (non-medical) [1] - Sales of first-class medical devices, daily necessities, personal hygiene products, and various retail and wholesale activities [1] - Consulting services in health, technology, and business management, as well as marketing planning and supply chain management [1] - The company is also authorized to engage in the rental of medical equipment and retail of pharmaceuticals, subject to regulatory approval [1]

Core Viewpoint - Shanghai Xingjingjie Glasses Co., Ltd. has been established with a registered capital of 100,000 RMB, indicating a new player in the eyewear market [1] Company Overview - The legal representative of the company is Zhang Jiamei [1] - The company is engaged in a wide range of business activities including the sale of glasses (excluding contact lenses), watches, jewelry, and various retail and wholesale services [1] Business Scope - The business scope includes general projects such as: - Eyewear sales (excluding contact lenses) - Watch sales - Retail and wholesale of jewelry [1] - Retail of photographic equipment and telescopes [1] - Sale of stationery and daily necessities [1] - Retail and wholesale of arts and crafts [1] - Computer hardware and software sales [1] - Internet sales (excluding licensed goods) [1] - Data processing and storage support services [1] - Equipment leasing services [1] - Advertising design and agency services [1] - Technical services and consulting [1] - Import and export of goods [1]

Core Viewpoint - Mingyue Lens, a leading lens brand in China, collaborates with Qianye Glasses to launch a campus public welfare campaign aimed at promoting vision health among children and adolescents, addressing the rising myopia rates in the country [1][5][8] Group 1: Campaign Overview - The campaign titled "Climbing to the Peak and Building Dreams for a Voyage" involves sharing learning experiences and myopia prevention knowledge with students in Chongqing [1] - Tsinghua University student leader Zhang Zhiyuan participated in the event, providing practical study techniques and encouraging students to adopt healthy eye care practices [1][3] Group 2: Myopia Statistics and Importance - According to the National Health Commission, the overall myopia rate among children and adolescents in China is projected to reach 52.7% by 2024, indicating that one in two students is affected [5] - The significance of myopia prevention is underscored by the alarming statistics, prompting initiatives like the public welfare campaign [5] Group 3: Product Offering - Mingyue Lens offers the "Mingyue Easy Control Lens," designed specifically for Chinese children's eye habits, balancing prevention effectiveness and comfort [5] - Clinical trials conducted by Zhongshan Ophthalmic Center and Tianjin Eye Hospital show that the lens has a myopia progression control effectiveness rate of 73.82%, with results published in the international journal "Ophthalmology" [5] Group 4: Social Responsibility - As a national brand, Mingyue Lens emphasizes its social responsibility by promoting myopia prevention awareness across the country, advocating for the protection of children's vision as a means to secure a brighter future [8]